Equities analysts predict that Quidel Co. (NASDAQ:QDEL) will report earnings per share of $0.78 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for Quidel’s earnings. The highest EPS estimate is $0.87 and the lowest is $0.74. Quidel posted earnings per share of $0.80 during the same quarter last year, which would indicate a negative year over year growth rate of 2.5%. The firm is scheduled to announce its next quarterly earnings report on Wednesday, February 12th.
On average, analysts expect that Quidel will report full-year earnings of $2.74 per share for the current year, with EPS estimates ranging from $2.70 to $2.84. For the next fiscal year, analysts expect that the firm will report earnings of $3.15 per share, with EPS estimates ranging from $2.89 to $3.57. Zacks’ earnings per share calculations are an average based on a survey of research firms that follow Quidel.
Quidel (NASDAQ:QDEL) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.70 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.64 by $0.06. The company had revenue of $126.50 million during the quarter, compared to analyst estimates of $125.52 million. Quidel had a net margin of 14.51% and a return on equity of 22.48%. The company’s revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the business posted $0.59 earnings per share.
A number of research firms recently issued reports on QDEL. ValuEngine upgraded shares of Quidel from a “sell” rating to a “hold” rating in a research report on Thursday, August 1st. Craig Hallum upgraded shares of Quidel from a “hold” rating to a “buy” rating and raised their price objective for the stock from $63.00 to $75.00 in a report on Thursday, August 29th. Zacks Investment Research upgraded shares of Quidel from a “sell” rating to a “hold” rating in a research report on Friday. Finally, TheStreet upgraded shares of Quidel from a “c+” rating to a “b” rating in a report on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. Quidel currently has a consensus rating of “Buy” and a consensus price target of $73.00.
In other Quidel news, CFO Randall J. Steward sold 29,328 shares of the business’s stock in a transaction that occurred on Monday, September 23rd. The stock was sold at an average price of $62.60, for a total value of $1,835,932.80. Following the completion of the transaction, the chief financial officer now directly owns 48,787 shares of the company’s stock, valued at $3,054,066.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kenneth F. Buechler sold 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 11th. The shares were sold at an average price of $68.86, for a total value of $275,440.00. Following the completion of the transaction, the director now directly owns 54,433 shares of the company’s stock, valued at $3,748,256.38. The disclosure for this sale can be found here. Insiders have sold 118,361 shares of company stock valued at $312,782,451 in the last ninety days. Corporate insiders own 14.10% of the company’s stock.
Institutional investors and hedge funds have recently modified their holdings of the stock. Pitcairn Co. grew its holdings in Quidel by 2.6% in the 2nd quarter. Pitcairn Co. now owns 7,214 shares of the company’s stock valued at $428,000 after buying an additional 182 shares in the last quarter. First Light Asset Management LLC lifted its stake in shares of Quidel by 0.5% in the 2nd quarter. First Light Asset Management LLC now owns 54,943 shares of the company’s stock valued at $3,259,000 after purchasing an additional 268 shares during the last quarter. Prudential Financial Inc. lifted its stake in Quidel by 7.6% during the 2nd quarter. Prudential Financial Inc. now owns 3,837 shares of the company’s stock worth $228,000 after acquiring an additional 270 shares in the last quarter. Tower Research Capital LLC TRC lifted its stake in Quidel by 190.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 589 shares of the company’s stock worth $35,000 after acquiring an additional 386 shares in the last quarter. Finally, United Services Automobile Association raised its position in Quidel by 4.8% in the 2nd quarter. United Services Automobile Association now owns 8,468 shares of the company’s stock valued at $502,000 after purchasing an additional 389 shares in the last quarter. Hedge funds and other institutional investors own 90.10% of the company’s stock.
Shares of NASDAQ QDEL traded up $0.80 during mid-day trading on Friday, hitting $59.55. 132,900 shares of the stock were exchanged, compared to its average volume of 208,108. Quidel has a twelve month low of $44.27 and a twelve month high of $70.31. The company has a market cap of $2.58 billion, a P/E ratio of 21.12 and a beta of 1.41. The stock’s fifty day simple moving average is $59.97 and its two-hundred day simple moving average is $59.45. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.83 and a current ratio of 1.46.
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology. The company offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a point-of-care products for the detection of infectious and inflammatory diseases and conditions of the eye.
Featured Article: What is a short straddle?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.